Clinical Trial Update: Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial protocol is described for evaluating adrenergic blockers to address cardiac changes in early Parkinson's disease, including participant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Rem Sleep Behavior Disorder

Snippet

Sponsor: Michele Tagliati, MD | Conditions: REM Sleep Behavior Disorder, Pre-motor Parkinson Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING